title: Verapamil improves Sandimmune immunosuppression, reducing acute rejection episodes.
authors.affiliation: Department of Surgery, Catholic University, Rome, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Citterio
authors.forename: F
authors.initials: F
authors.lastname: Serino
authors.forename: U
authors.initials: U
authors.lastname: Pozzetto
authors.forename: P
authors.initials: P
authors.lastname: Fioravanti
authors.forename: P
authors.initials: P
authors.lastname: Caizzi
authors.forename: M
authors.initials: M
authors.lastname: Castagneto
mesh_terms: D000284:Administration, Oral; D000328:Adult; D016572:Cyclosporine / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D015994:Incidence; D007262:Infusions, Intravenous; D016030:Kidney Transplantation / Q000276:immunology*; D014700:Verapamil / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D014700:Verapamil